DUBLIN--(BUSINESS WIRE)--The "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering.
The report analyzes the Chemotherapy Drugs Market for the historical period of 2013-2017 and the forecast period of 2018-2023. According to the report, the market is projected to display a robust growth represented by a CAGR of 11.91% during 2018-2023.
On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc.
Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments.
Scope of the Report
Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
- Global Chemotherapy Drugs Market - Size, Growth, Forecast
- By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
- By Route of Administration (Oral, Intravenous, Others)
Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Regional Chemotherapy Drugs Market - Size, Growth, Forecast
- By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
- By Route of Administration (Oral, Intravenous, Others)
Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Chemotherapy Drugs Market - Size, Growth, Forecast
- By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
- By Route of Administration (Oral, Intravenous, Others)
Other Report Highlights
- Market Dynamics - Drivers and Restraints
- Market Trends
- SWOT Analysis
- Porter Five Force Analysis
- Policy and Regulatory Landscape
- Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited
Key Topics Covered
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Chemotherapy Drugs Market Outlook
5. Global Chemotherapy Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Chemotherapy Drugs Market: Segment Analysis
6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)
6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)
6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)
6.4 Other Chemotherapy Drugs Market, By Value (2013-2023)
6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)
6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)
6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)
6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023)
6.7 Other Chemotherapy Drugs Market, By Value (2013-2023)
7. Global Chemotherapy Drugs Market: Regional Analysis
7.1 Global Chemotherapy Drugs Market Size, By Region: Breakdown (%)
7.2 North America Chemotherapy Drugs Market: Growth and Forecast
7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada)
7.4 Europe Chemotherapy Drugs Market: Growth and Forecast
7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)
7.6 APAC Chemotherapy Drugs Market: Growth and Forecast
7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China)
7.8 ROW Chemotherapy Drugs Market: Growth and Forecast
8. Global Chemotherapy Drugs Market Dynamics
8.1 Global Chemotherapy Drugs Market Drivers
8.2 Global Chemotherapy Drugs Market Restraints
9. Global Chemotherapy Drugs Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Policy and Regulatory Landscape
14. Company Profiles
14.1 Pfizer
14.2 Eli Lilly & Company
14.3 CELGENE Corporation
14.4 Bristol-Myers Squibb
14.5 Merck & Co. Inc.
14.6 GlaxoSmithKline PLC
14.7 Novartis
14.8 Sanofi
14.9 Teva Pharmaceuticals Industries Limited
For more information about this report visit https://www.researchandmarkets.com/r/sghees